- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03227601
Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome
July 20, 2017 updated by: Labibe Mara Pinel Frederico, Universidade Federal de Pernambuco
Effect of a Posture Adapter Use on Body Alignment in Standing Position on Children Between 12 and 24 Months Old With Zyka Virys Congenital Syndrome
Congenital Zika virus syndrome (SCZv) has been gaining attention in studies due to changes in the central nervous system and in the motor development of children.
These changes resulted in an unexpected picture and without future predictability, with the appearance of several functional impairments and also on orthostatic posture.
In this context, the protocol of orthostatism proposed here is a 10-week program of the use of a postural adjuster, the standing frame, made of its own with alternative material to the commercial models (cardboard).
The use of low cost materials allows these devices to be made in the desired size without cost high, individually adapted, easy to be transported as it is light and can still be colored.
It is an equipment that offers the opportunity to experience the orthostatic posture and mainly benefits children with little economic resources that enable the acquisition of traditional devices made of iron or wood and even imported equipment.
The postural adjuster allows physical and sensorial opportunity, being an auxiliary resource in standing positioning, feasible for home use, besides being useful for performing functional activities.
Thus, the objective will be to analyze the repercussions of the use of the standing frame on body alignment, muscle tone, gross motor function and gastrointestinal functions of children with SCZv.
An uncontrolled intervention study will be conducted with children between 12 and 24 months of age, who will undergo an evaluation before use and after the use of the adjunct along with the proposed orthostatism protocol.
The postural alignment will be evaluated through photogrammetry and the evaluation of muscle tone will be performed through the modified Tardieu scale.
The Gross Motor Function Measure (GMFM) scale will be used to assess the gross motor function of the children involved in the study.
Questionnaires will be applied for the collection of maternal socio-demographic data, the child's data, the type and time of therapy that the child already participates, and the gastrointestinal functions.
Evaluations will occur in four moments: initial / before use, on the first day of placement in the adjuster, after the first month after use and after the second month of use.
For statistical analysis, the Shapiro Wilk Test will be applied to evaluate the normality of the data, and the Friedman or ANOVA tests for repeated samples, to analyze intra-group time factor for the dependent variables of each individual.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 50.740-545
- Recruiting
- Universidade Federal de Pernambuco
-
Contact:
- Labibe Mara Pinel Frederico
- Phone Number: +5581991165364
- Email: labibep@gmail.com
-
Contact:
- Karla Monica Ferraz Lambertz
- Phone Number: +558199994-1064
- Email: karla_monica@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- children between 12 and 24 months old;
- children with confirmed zika virus infection diagnosis;
- children with STORCH + for zika virus (blood test)
Exclusion Criteria:
- children with no medication for controlling zika virus infection symptoms;
- children with musculoskeletal disorders or limitation to standing position
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Alignment
Time Frame: two-month period
|
Position or attitude of the body, the Arrangement of the parts of the body for a specific activity, or a Characteristic way of someone sustaining your body
|
two-month period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor function
Time Frame: two-month period
|
Ability to carry out human development stages
|
two-month period
|
|
Gastrointestinal function
Time Frame: two-month period
|
intestinal motility
|
two-month period
|
|
Muscular tonus
Time Frame: two-month period
|
basal level of muscle contraction
|
two-month period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2017
Primary Completion (Anticipated)
October 19, 2017
Study Completion (Anticipated)
August 31, 2018
Study Registration Dates
First Submitted
July 20, 2017
First Submitted That Met QC Criteria
July 20, 2017
First Posted (Actual)
July 24, 2017
Study Record Updates
Last Update Posted (Actual)
July 24, 2017
Last Update Submitted That Met QC Criteria
July 20, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1808
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Zika Virus
-
TakedaCompletedFlavivirus Infections | Healthy Participants | Virus, Zika | Zika Virus DiseaseUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
Institute of Tropical Medicine, BelgiumCompletedTransmission | Zika Virus | Zika Virus Disease | Virus SheddingBelgium
-
Valneva Austria GmbHCompletedZika | Zika Virus InfectionUnited States
-
Emergent BioSolutionsCompletedZika Virus Infection | Zika Virus DiseaseCanada
-
Kathryn StephensonNational Institute of Allergy and Infectious Diseases (NIAID); Walter Reed...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
Northwestern UniversityPontificia Universidad Catolica Madre y MaestraWithdrawnZika Virus Symptoms and the Associated ExanthemaDominican Republic
-
Sanofi Pasteur, a Sanofi CompanyCompletedZika Virus DiseaseColombia, Honduras, Mexico, Puerto Rico
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
Clinical Trials on posture adapter
-
Columbia UniversityState University of New York - Downstate Medical CenterWithdrawn
-
PATHSID TechnologiesCompletedInjections, IntradermalUnited States
-
Boehringer IngelheimTerminated
-
Cardiff and Vale University Health BoardCompletedIntensive CareUnited Kingdom
-
PATHCompletedInjections, IntradermalUnited States
-
Endeavor HealthWithdrawnEvaluation of Leak-Free Bronchoscope Adapter to Limit Ventilated Air Volume Loss During BronchoscopyPulmonary DiseaseUnited States
-
University of ManitobaRehabilitation Centre for Children, CanadaRecruitingPediatric | Upper Limb Amputation at the Hand | Upper Limb Amputation at the Wrist | Upper Limb Amputation Below Elbow (Injury) | Upper Limb Amputation | Amniotic Band SyndromeCanada
-
Rigshospitalet, DenmarkCompleted
-
University of New MexicoNational Institute of Mental Health (NIMH)RecruitingDepression | Cognitive Change | ECTUnited States
-
Hospital Moinhos de VentoHospital Ernesto DornellesTerminated